The median corporate profit margin in the US is 7.5% - in the Pharmaceutical Industry it’s 16%. There’s a reason for that. In the US there are essentially single company monopolies on specific drugs and the FDA protects them. In other countries around the world, the same companies have to charge a significantly lower price, why you may ask? Because there are 9 to 10 companies producing the exact same drug, competing with each other. In the developed world, the US has among the highest health care costs, and the mainstream media and politicians blame it on the big bad greedy capitalists. Instead of explaining that the health care industry, not just pharmaceuticals, the entire industry is a crony industry built around subsidies and access to Medicare patients, at the federal and state levels.
That money comes with a lot of strings. If you check out the links at the bottom of this blog post attached, it goes directly to the federal register search for economically significant rules and regulation for two different federal agencies, FDA and Health & Human Services. The FDA in particular is an atrocious bureaucracy that would rather let people that have diseases with NO Cure die than to allow them to consent to taking risky experimental drugs that, you know what, just might save their life.’
The FDA also as a matter of doing business, doesn’t like to, for whatever reason, approve multiple versions of the same drug if there is no reason to, and just showing an identical chemical compound doesn’t get you throw trials – rather the FDA has taken approach of allowing a single company a monopoly over specific drugs. In some cases, lifesaving drugs.
Tonight on TheMacroView Host Andrew N. Smith discusses why this is so dangerous